Exclusive

Publication

Byline

Location

US Patent Issued to nLIGHT on Sept. 29 for "Functionally homogenized intensity distribution for additive manufacturing or other industrial laser processing applications" (Washington, Oregon Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,599, issued on Sept. 29, was assigned to nLIGHT Inc. (Camas, Wash.). "Functionally homogenized intensity distribution for additive manufac... Read More


US Patent Issued to DIVERGENT TECHNOLOGIES on Sept. 29 for "Exchangeable beam entry window for am system" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,601, issued on Sept. 29, was assigned to DIVERGENT TECHNOLOGIES INC. (Los Angeles). "Exchangeable beam entry window for am system" was inv... Read More


US Patent Issued to SPECNOVA on Sept. 29 for "Method of inhibiting dopamine transporter activity" (British, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,217, issued on Sept. 29, was assigned to SPECNOVA LLC (Tysons Corner, Va.). "Method of inhibiting dopamine transporter activity" was inven... Read More


US Patent Issued on Sept. 29 for "Methods for treating cancers" (Taiwanese Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,218, issued on Sept. 29. "Methods for treating cancers" was invented by Shauh-Der Yeh (New Taipei City, Taiwan). According to the abstrac... Read More


US Patent Issued to Hadasit Medical Research Services & Development, Yissum Research Development Company of the Hebrew University of Jersusalem on Sept. 29 for "Methods and compositions for preventing skin toxicities caused by biological targeted cancer drugs" (Israeli Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,219, issued on Sept. 29, was assigned to Hadasit Medical Research Services & Development Ltd. (Jerusalem) and Yissum Research Development C... Read More


US Patent Issued to INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY on Sept. 29 for "Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease" (South Korean, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,220, issued on Sept. 29, was assigned to INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (Seoul, South Korea). "Pharmaceutical... Read More


US Patent Issued to Ascentage Pharma (Suzhou), Ascentage Pharma Group on Sept. 29 for "Combinations of Bcl-2/Bcl-xL inhibitors and related uses" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,221, issued on Sept. 29, was assigned to Ascentage Pharma (Suzhou) Co. Ltd. (Suzhou, China) and Ascentage Pharma Group Corp Ltd. (Hong Kong... Read More


US Patent Issued to Foundry Therapeutics on Sept. 29 for "Implantable depots for localized, sustained, controlled release of therapeutic agents to treat cancer and related conditions" (Singaporean, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,222, issued on Sept. 29, was assigned to Foundry Therapeutics Inc. (Menlo Park, Calif.). "Implantable depots for localized, sustained, con... Read More


US Patent Issued to APRECIA PHARMACEUTICALS on Sept. 29 for "Rapid disperse dosage form" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,223, issued on Sept. 29, was assigned to APRECIA PHARMACEUTICALS LLC (Mason, Ohio). "Rapid disperse dosage form" was invented by Jules Jac... Read More


US Patent Issued to ETH ZURICH on Sept. 29 for "Compounds for treating CNS- and neurodegenerative diseases" (Swiss, German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,224, issued on Sept. 29, was assigned to ETH ZURICH (Zurich). "Compounds for treating CNS- and neurodegenerative diseases" was invented by... Read More